News

American Express: Insights on Upcoming Earnings and Expectations

American Express: Insights on Upcoming Earnings and Expectations

Introducing American Express Company

American Express Company (NYSE: AXP) stands as a significant player in the financial services sector. As we approach the third-quarter earnings report, there is heightened anticipation around the company's performance, especially following a series of solid results in previous quarters.

Earnings Estimates and Historical Performance

Analysts are expecting American Express to report a third-quarter revenue of approximately $18.05 billion, a noticeable increase from $16.64 billion seen in the same period last year. This reflects a positive growth trajectory that the company has maintained.

The firm has consistently exceeded analyst expectations for revenue, achieving this in three consecutive quarters and in six out of the last ten quarters. Additionally, earnings per share (EPS) are anticipated to come in at $4.00, marking an increase from $3.49 in the third quarter of the previous year.

Analysts’ Insights

In a recent commentary, Truist Securities analyst Brian Foran reaffirmed a Buy rating with a price target of $375 on American Express shares. He highlighted that the updated Platinum card, despite receiving mixed reviews, shows potential for enhanced demand based on user feedback.

Foran pointed out that while the new higher annual fee is a concern, surveys indicate that most cardholders are inclined to renew their subscriptions, suggesting a robust customer base ready to accept the changes.

Nevertheless, he cautioned that the company must manage escalating marketing and technology costs, which might surpass revenue growth, alongside the possibility of credit deterioration amid economic uncertainties.

Analyst Ratings and Price Targets

The analyst landscape for American Express remains optimistic, with various firms adjusting their price targets upwards. Notably:

  • UBS has maintained a Neutral rating, increasing the price target from $330 to $340.
  • JPMorgan also upheld a Neutral rating while raising its price target from $343 to $355.
  • Barclays decided on an Equal-Weight rating, boosting their price target from $297 to $336.
  • Keefe, Bruyette & Woods has kept an Outperform rating, raising the target from $371 to $394.
  • Evercore ISI Group maintained an In-Line rating and lifted the price target from $330 to $365.

Key Factors to Monitor

As anticipation builds for the earnings report, American Express's recent upgrades in perks and fees will likely be in focus. Investors will look for insights on consumer demand and potential cancellations linked to the higher fee structure.

The company is aiming to attract Millennials and Gen Z consumers, offering new benefits designed for these demographics, which account for about 35% of their customer base—an increase from 19% in 2019. This strategic shift could help mitigate the effects of the elevated fees.

Recent Financial Performance

In its previous quarter, American Express reported strong growth in Card Member spending, alongside a noteworthy increase in net interest income. Revenue, after accounting for interest expenses, rose by 9% year-on-year.

Moreover, Card Member spending surged by 7% year-on-year, totaling $416.3 billion in the last reported quarter. This metric is crucial as it provides insights into the ongoing growth of the company and serves as a barometer for the broader U.S. economy.

The International Card Services segment witnessed an impressive 14.5% growth year-on-year, contrasting with a 3.2% increase in Global Merchant and Network Services revenue.

Given these performance indicators, analysts will be keenly observing the company’s expense trends, which rose by 14% year-over-year previously. A crucial point of interest will be whether the growth in costs is outpaced by revenue enhancements.

The Berkshire Connection

American Express holds a significant position within Berkshire Hathaway Inc. (NYSE: BRK), where it constitutes around 16.7% of the investment portfolio. The conglomerate, led by the esteemed Warren Buffett, holds approximately 21.8% of American Express shares.

This connection not only underscores the intrinsic value seen in American Express but also hints at potential market impacts from its quarterly results on the Dow Jones Industrial Average, as it remains one of the index's largest constituents.

Current Stock Performance

As of recent trading, American Express shares were priced at $333.02, which falls within its 52-week trading range of $220.43 to $349.19. The stock has shown a year-to-date increase of 11.6% as of the latest market close.

Frequently Asked Questions

What are the expected earnings for American Express this quarter?

Analysts expect American Express to report earnings of approximately $4.00 per share.

How does the current year compare to last year’s quarter?

This year’s revenue is expected to be around $18.05 billion, up from $16.64 billion in the same quarter last year.

What are the challenges facing American Express?

American Express faces challenges such as rising marketing costs and possible credit deterioration due to a weaker economic landscape.

Who are the significant stakeholders in American Express?

American Express is a major holding for Berkshire Hathaway, which has a 21.8% stake in the company.

How has American Express’s stock performed this year?

The stock is up 11.6% year-to-date, showing resilience and growth in the current market conditions.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Gold Prices Climb; Miners Stick to Guidance Amid Stress

Updated Category News Views 110

Wham, pow! Gold's climbing up to the skies again. As if the shiny stuff needed more fanfare, there it is, breaking above $4,000 an ounce. Remember when it couldn't hold a candle to $1,500? Now the December gold futures are planting themselves firmly at $4,124.10. That's a healthy leap from Friday's close by $49.20. How about that for a head-turner? Miners Holding the Line...

Continue Reading
Credit Union Teams Up for Holiday Toy Drive in San Diego

Updated Category News Views 70

San Diego's Seasonal Giving: A Community Effort Hold onto your hats, folks—it's that time of the year when giving isn't just a suggestion; it's a full-fledged community rallying cry. Heading into the joyful chaos is North Island Credit Union, teaming up with Boys & Girls Clubs of Greater San Diego to bring the spirit of the season to children across the region. Through...

Continue Reading
WSIB Slashes Registration Time with Guidewire Boost

Updated Category News Views 63

Quick Fix: Streamlining Ontario's Employer Registration Alright, let's cut through the formalities and tell it like it is: Ontario's Workplace Safety and Insurance Board (WSIB) isn't messing around anymore. They've yanked their antiquated paper-laden process into the digital age, slicing the employer registration wait down from an agonizing eight to ten-day ordeal to a...

Continue Reading
Protalix Unveils Promising Gout Therapy Data at ACR 2026

Updated Category News Views 42

A Glimmer of Hope for Gout Sufferers Uncontrolled gout patients may soon see a light at the end of the tunnel. Protalix BioTherapeutics (NYSE American: PLX) just rolled out data at the ACR Convergence 2026, underscoring the potential of their drug candidate, PRX-115. This revelation is a big deal for those grappling with gout that just won't quit, constantly pelted by...

Continue Reading
Delta Marks 19 Years at COP With Bold New Initiatives

Updated Category News Views 150

Delta's Commitment to Global Sustainability Delta's name pops up yet again at the United Nations Climate Change Conference (COP31) in Antalya, Turkey, marking the company's 19th consecutive year of participation. They're mounting efforts to hit that "35×35" target, aiming for 35% electrification by 2035. This isn't just fluff and rhetoric—it’s Delta taking the lead...

Continue Reading
Empyrean Eases Public Sector Benefits with OMNIA Deal

Updated Category News Views 126

In a world where bureaucratic red tape often chokes efficiency, Empyrean throws a lifeline to public sector bodies. They've nabbed a cooperative purchasing contract with OMNIA Partners, dialing down the procurement guts to make benefits administration easier for government and education folks. Streamlining Public Sector Procurement Public sector organizations ain't...

Continue Reading
Smart Cooling Accessory: A Game Changer for AC Units?

Updated Category News Views 76

New Kid on the Block: The Smart Cooling Game They say the devil's in the details, and this one’s got all the right tweaks. Picture this — a compressor-based air conditioning system beefing up with a savvy accessory that promises to give your condenser coil some extra muscle. That's right, we've got ourselves a new contender in the cooling corner: THE CSC UNIT. It's...

Continue Reading
QuidelOrtho Shares Plunge 14% Amid Legal Scrutiny

Updated Category News Views 25

QuidelOrtho's Rocky Road Oh, it's been a roller coaster for QuidelOrtho's stock. Lately, it’s like holding onto a greased pole in a thunderstorm. November 9th, 2026, wasn't a friend to QDEL shareholders; the stock's down about 14%, and now some legal eagles want to know if there's more to the story. When you go poking around in the financials and spotlight that nasty...

Continue Reading
Children's Institute Gala Raises $4M: A Night to Remember

Updated Category News Views 82

Breaking Records and Honoring Legends You know, sometimes there's more to the world than stocks and ticker tapes. Over in Los Angeles, the Children's Institute pulled off a real spectacle with their Annual Cape & Gown Gala, drawing in more than 600 folks and raking in a whopping $4 million. That's right, four million clams in one evening—a record-breaker for them. When...

Continue Reading
Mako Hiraizumi Shines with Silver at Japan Triathlon

Updated Category News Views 146

A Triathlete with Grit and Ambition Mako Hiraizumi didn't just earn a silver medal at the 32nd Japan Triathlon National Championships; she set an example of perseverance and ambition. Rising a notch from her bronze finish last year, Hiraizumi's runner-up achievement at Tokyo's Odaiba Seaside Park is no small feat. Yet, she's not resting on her laurels. This athlete from...

Continue Reading

Top 5 Most Recently Viewed Articles

Oakworth Capital Inc. Delivers Consistent Annual Dividend Growth

Updated Category News Views 149

Oakworth Capital Inc. Declares Annual Dividend The Board of Directors of Oakworth Capital Inc. met recently and announced a notable achievement: an annual dividend of $0.45 per common share. This marks the 10th consecutive year that the company has provided a cash dividend to its shareholders, showcasing their commitment to returning value to investors. Amazing...

Continue Reading
SELLAS Life Sciences Group Targets Major Milestones Ahead

Updated Category News Views 204

SELLAS Life Sciences Group Moves Forward with Cancer Research SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) is taking significant steps in advancing its cancer therapies, aiming for pivotal milestones that are expected in the coming years. With a market capitalization of approximately $74 million, this late-stage clinical biopharmaceutical company is on the verge of...

Continue Reading
Fortran Corporation's Strategic Move to Acquire Intech Systems

Updated Category News Views 152

Fortran Corporation Makes Significant Acquisition Move Fortran Corporation (OTC: FRTN) has recently signed a Letter of Intent (LOI) that heralds a promising new chapter for the company. This LOI is aimed at acquiring Intech Systems of South Carolina, Inc., a significant player in telecommunication sales and services. Impacts of the Acquisition The company’s President,...

Continue Reading
Action Alert: Novo Nordisk (NYSE: NVO) Investors Required to Act Soon

Updated Category News Views 164

Urgent Notice for Novo Nordisk (NYSE: NVO) Investors As the situation develops, investors in Novo Nordisk A/S, a renowned global pharmaceutical company, are advised to stay informed about a potential securities fraud class action. This comes in light of recent legal challenges aimed at the company, and those holding Novo securities need to take notice. Investor Action...

Continue Reading
Galan Lithium Secures A$20 Million Commitment from Clean Elements

Updated Category News Views 303

Galan Lithium Limited Announces Strategic A$20 Million Placement Galan Lithium Limited (ASX:GLN) is excited to share that it has successfully obtained a binding commitment for a significant A$20 million placement at A$0.11 per share. This represents a remarkable 21% premium over the most recent closing price of A$0.091, showcasing the confidence investors have in the...

Continue Reading